Login / Signup

Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.

Sara RaponiIlaria Del GiudiceCaterina IlariLuciana CafforioMonica MessinaLuca V CappelliSilvia BoninaAlfonso PiciocchiMarilisa MarinelliNadia PeraginePaola MarigliaFrancesca Romana MauroGian Matteo RigolinFrancesca RossiRiccardo BombenMichele Dal BoGiovanni Del PoetaFary DiopChiara FaviniDavide RossiGianluca GaidanoAntonio CuneoValter GatteiAnna GuariniRobin Foá
Published in: British journal of haematology (2018)
Keyphrases
  • genome wide
  • intellectual disability
  • randomized controlled trial
  • clinical trial
  • autism spectrum disorder
  • drug induced
  • study protocol